| Offering Information |
| Expected Date | - |
| Proposed Exchange/Ticker |
Nasdaq: TLCR |
| Security Type |
Common Stock |
| Lead Underwriter |
Morgan Stanley Goldman Sachs & Co Citi JP Morgan |
| Days In Registration |
687 |
| Date Filed |
13-Nov-2007 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2008) |
| Industry |
Manufacturing |
| Business Description |
Talecris Biotherapeutics Holdings Corp, located in Research Triangle Park, North Carolina, is a biopharmaceutical company that produces and markets plasma-derived protein therapies. The company has locations in Toronto, Canada and Frankfurt, Germany. The company's services include prolastin/gamunex direct, contract manufacturing services, and talecris plasma resources. The company was founded in 2005. |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
119.78M |
| Contact |
- |
| Number of Employees |
4000 |
|
| Original Filing Information |
| US |
| Shares Filed |
- |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
- |
| · As a Percent |
- |
| Overallotment Shares Filed |
6000.0K |
| File Amount |
- |
| File Price Range |
- - - |
| File Mid Price |
- |
Current Filing Information
(Amended 19-Oct-2007) |
|
US |
|
Shares Filed |
- |
| Secondary Shares Filed |
- |
| · As a Percent |
- |
| Primary Shares Filed |
- |
| · As a Percent |
- |
| Overallotment Shares Filed |
- |
| File Amount |
- |
| · % Change from Original |
|
| File Price Range |
$20.00 - $18.00 |
| File Mid Price |
$19.00 |
|
